Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOB015B vs Ciclopirox in Mild to Moderate Distal Subungual Onychomycosis
NCT02866032Phase 3Completed
- Sponsor
- Moberg Pharma AB
- Start
- Sep 2016
- Primary completion
- Jun 2020
- Modality
- Transdermal Patches, Orthosteric Ligands, Hydrogel Systems
- Countries
- 3
01
Overview
A Phase 3 trial of Terclara in distal subungual onychomycosis (DSO), sponsored by Moberg Pharma AB. Started Sep 2016; status: completed.
02
Drugs
Terclara
03
Conditions
distal subungual onychomycosis (DSO)
Beyond the preview
Go deeper on NCT02866032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02866032.